American Society of Gene & Cell Therapy

About the American Society of Gene & Cell Therapy

The American Society of Gene & Cell Therapy (ASGCT) is a leading organisation dedicated to advancing the field of gene and cell therapy. Established with the vision of promoting research, education, and clinical application of these innovative therapies, ASGCT plays a pivotal role in shaping the future of medicine.

With a strong commitment to scientific excellence, ASGCT provides a platform for researchers, clinicians, and industry professionals to collaborate and share knowledge. The society hosts annual meetings, workshops, and educational programs that foster dialogue and innovation within the community.

ASGCT is also actively involved in advocacy efforts, working to influence policy and regulatory frameworks that impact gene and cell therapy. By engaging with stakeholders, the society aims to ensure that patients have access to safe and effective treatments.

In addition to its advocacy work, ASGCT publishes a range of resources, including journals, newsletters, and guidelines that serve as valuable references for professionals in the field. These publications highlight the latest research findings and clinical advancements, keeping members informed and engaged.

The society is committed to fostering diversity and inclusion within the gene and cell therapy community. ASGCT encourages participation from underrepresented groups and supports initiatives that promote equity in research and clinical practice.

Through its various programs and initiatives, ASGCT strives to enhance public understanding of gene and cell therapy. The society believes that educating the public about these transformative therapies is essential for building trust and support within the healthcare system.

Overall, the American Society of Gene & Cell Therapy is at the forefront of a rapidly evolving field, dedicated to improving patient outcomes through innovative research and collaboration.